Regarding NG entering a losing battle, I agree. Especially after a giant rival like Boeing stepping in on our side. The question remains, though, is whether or not they would be entering a losing battle. I can't figure out how I should view NG's relative quietness regarding the whole BioWatch Gen 3. Are they giving up on it for now? Are they simply not talking a lot about it since it's not their main scope of interest? Or are they not showing all of their cards and keeping their aces in the hole to be shown during the actual testing?
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.